Sean Ekins and Filippa Lentzos on a Teachable Moment for Dual-Use

episode

The Lawfare Podcast not yet transcribed

▲ 0

Transcript

This episode hasn't been transcribed yet Upvotes decide what gets transcribed next — 0 so far. Sign in to upvote

More from The Lawfare Podcast

Lawfare Archive: Memorializing Babyn Yar after the Russian Invasion of Ukraine 44 min · 20 Dec 2025

All episodes from The Lawfare Podcast →

Report any issue

Source

Recorded26 Aug 2022

Publisherfeeds.acast.com ↗

Handlerec:2525788

Show notes

Back in March, a team of researchers published an article in Nature Machine Intelligence showing that a drug discovery company’s AI-powered molecule generator could have a dangerous dual use: The model could design thousands of new biochemical weapons in a matter of hours that were equally as toxic as, if not more toxic than, the nerve agent VX. Lawfare associate editor Tia Sewell sat down with two of the paper’s authors: Dr. Filippa Lentzos, senior lecturer in science & international security at the Department of War Studies at King’s College London, and Dr. Sean Ekins, CEO of Collaborations Pharmaceuticals. They discussed the story of their discovery and their reaction to it, as well as how we should think about dual-use artificial intelligence threats more broadly as new technologies expand the potential for malicious use. They also got into why governments need to work more proactively to address the challenges of regulating machine learning software.Support this show http://supporter.acast.com/lawfare. Hosted on Acast. See acast.com/privacy for more information.

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.